Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct;44(9):631-6.
doi: 10.1097/MCG.0b013e3181d47f5b.

Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations

Michael D Williams  1 , Christina Y Ha, Matthew A Ciorba
Affiliations

Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations

Michael D Williams et al. J Clin Gastroenterol. 2010 Oct.

Abstract

Goals: The objective of this study was to determine how gastroenterologists perceive and use probiotic-based therapies in practice.

Background: In the United States, there has been a recent increase in research investigating the therapeutic capacities of probiotics in human disease and an accompanying increase in product availability and marketing. How medical care providers have interpreted the available literature and incorporated it into their practice has not been earlier assessed.

Study: A 16-question survey (see Survey, Supplemental Digital Content 1, http://links.lww.com/JCG/A14) was distributed to practicing gastroenterologists and physicians with a specific interest in GI disorders within a large metropolitan area.

Results: All physicians responded that they believed probiotics to be safe for most patients and 98% responded that probiotics have a role in treating gastrointestinal illnesses or symptoms. Currently 93% of physicians have patients taking probiotics most often for irritable bowel syndrome. Commonly used probiotics included yogurt-based products, Bifidobacterium infantis 35624 (Align), and VSL#3. Most surveyed physicians recommended probiotics for irritable bowel syndrome, antibiotic, and Clostridium difficile-associated diarrhea because they believed that the literature supports their usage for these conditions. However, physician practice patterns did not consistently correlate with published, expert-panel-generated recommendations for evidence-based probiotic use.

Conclusions: This study suggests most gastrointestinal disease specialists recognize a role for and have used probiotics as part of their therapeutic armamentarium; however, the effective implementation of this practice will benefit from additional supporting studies and the eventual development of clinical practice guidelines supported by the major gastroenterology societies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest or industry support for this work.

Figures

Figure 1
Figure 1
Conditions for which physicians believe literature supports probiotic usage.
Figure 2
Figure 2
Conditions for which physicians recommended probiotics in practice.
See this image and copyright information in PMC

Comment in

References

    1. Floch MH, Madsen KK, Jenkins DJ, et al. Recommendations for probiotic use. J Clin Gastroenterol. 2006;40:275–278. - PubMed
    1. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620–1633. - PubMed
    1. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis. 2008;14:1585–1596. - PubMed
    1. Ciorba MA, Stenson WF. Probiotic therapy in radiation-induced intestinal injury and repair. Ann N Y Acad Sci. 2009;1165:190–194. - PMC - PubMed
    1. Floch MH, Walker WA, Guandalini S, et al. Recommendations for probiotic use—2008. J Clin Gastroenterol. 2008;42(suppl 2):S104–S108. - PubMed

MeSH terms